000			02016 a2200553 4500
005			20250517170923.0
264		0	_c20180905
008			201809s 0 0 eng d
022			_a1568-5608
024	7		_a10.1007/s10787-017-0386-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aJafarnezhad-Ansariha, Fahimeh
245	0	0	_aThe effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line. _h[electronic resource]
260			_bInflammopharmacology _cApr 2018
300			_a375-384 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAnimals
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aCell Line
650	0	4	_aCyclooxygenase 1 _xmetabolism
650	0	4	_aCyclooxygenase 2 _xmetabolism
650	0	4	_aFemale
650	0	4	_aGene Expression _xdrug effects
650	0	4	_aHexuronic Acids _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInflammation _xdrug therapy
650	0	4	_aIran
650	0	4	_aMacrophages _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMonocytes _xdrug effects
650	0	4	_aSpondylitis, Ankylosing _xdrug therapy
700	1		_aYekaninejad, Mir Saeed
700	1		_aJamshidi, Ahmad-Reza
700	1		_aMansouri, Reza
700	1		_aVojdanian, Mahdi
700	1		_aMahmoudi, Mahdi
700	1		_aFattahi, Mohammad Javad
700	1		_aHashemi, Seyed Naser
700	1		_aRehm, Bernd H A
700	1		_aMatsuo, Hidenori
700	1		_aEsposito, Emanuela
700	1		_aCuzzocrea, Salvatore
700	1		_aMirshafiey, Abbas
773	0		_tInflammopharmacology _gvol. 26 _gno. 2 _gp. 375-384
856	4	0	_uhttps://doi.org/10.1007/s10787-017-0386-4 _zAvailable from publisher's website
999			_c27476989 _d27476989